Aim: To study asthenia in adolescents with attention deficit hyperactivity disorder (ADHD) and assess the efficacy of nooclerin.
Material And Methods: We examined 60 patients, aged from 12 to 15 years, with ADHD. A comparative analysis of ADHD demonstrated the predominance of an inattentive type (ADHD-I) and a combined type (ADHD-C).
Results And Conclusion: Symptoms of asthenia were found in 56% of adolescents with ADHD-C and in 96.7% with ADHD-I. The high efficacy and safety of nooclerin in the treatment of ADHD was demonstrated. The improvement of mental state was achieved in 76.7% of patients with ADHD-I and in 53.3% patients with ADHD-C.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.17116/jnevro20151155242-45 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!